Diagnostic Performance and Test Savings of Pooled Testing for Molecular Detection of Tuberculosis: A Diagnostic Accuracy Study across Seven Countries
Abstract
Background: In 2024, only 54% of people diagnosed with tuberculosis received an initial WHO-recommended rapid molecular diagnostic test. Pooled testing could expand access to molecular detection using existing laboratory capacity. We evaluated the performance of pooled TB testing in a multicentre diagnostic accuracy study.<br><br>Methods: We recruited individuals with presumptive tuberculosis through facility-based case finding (district hospitals and primary health centres) and community-based case finding. Sputum was tested individually on Xpert MTB/RIF Ultra (Xpert Ultra) and in pools of two, three or four specimens on Xpert Ultra. Culture was used as the microbiological reference standard. We estimated the sensitivity and specificity of pooled testing versus culture, positive percent agreement (PPA) versus individual Xpert Ultra, and cartridge savings.<br><br>Findings: Results were available for 14,040 (95·2%) participants from 3,666 pools, including 3,195 (87·2%) pools of four. Using culture as the reference standard, sensitivity and specificity of pooled testing versus individual Xpert Ultra were 84·9% (95% CI 82·5–87·0) versus 88·0% (85·9–90·0) and 98·3% (98·0–98·5) versus 97·7% (97·4–97·9), respectively. PPA was 90·1% (95% CI 88·4–91·7), remaining high for high, medium, and low individual Xpert Ultra semiquantitative grades (98·1% [96·1–99·2], 98·3% [95·8–99·5], and 96·5% [93·8–98·2]), but lower for very low (86·6% [79·9–91·7]) and trace (55·4% [47·9–62·7]). Pooled testing used 7,028 cartridges versus 14,362 for individual testing, a 51·1% reduction.<br><br>Interpretation: Pooled testing with Xpert Ultra had slightly higher specificity and a 3·2% lower sensitivity compared to individual Xpert Ultra, while halving cartridge use. Scale-up of this testing approach may facilitate expanded access to molecular tuberculosis diagnosis without the need for additional infrastructure.
Fields of Study & Subjects
Tuberculosis Research and Epidemiology
SARS-CoV-2 detection and testing
Biosensors and Analytical Detection
Publication details
- Journal / source
- SSRN Electronic Journal
- Publisher
- Elsevier BV
- Publication date
- 1 January 2026
- Document type
- Preprint